References
- Blank CA, Brantly M. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency. Ann Allergy 1994; 72(2):105–20 [Erratum, Ann Allergy 1994; 72(4):305]
- Buist AS. Alpha1antitrypsin deficiency-diagnosis, treatment, and control: identification of patients. Lung 1990; 168(Suppl):543–51
- Crystal RG. Alpha1antitrypsin deficiency: pathogenesis and treatment. Hosp Pract (Off Ed) 1991;26(2):81–94
- Weiss EB, Stein M, eds. Bronchial asthma: mechanisms and therapeutics. 3d ed. Boston: Little, Brown, 1993
- Silverman EK, Miletich JP, Pierce JA, et al. Alpha-1-antitrypsin deficiency: high prevalence in the St Louis area determined by direct population screening. Am Rev Respir Dis 1989;140(4):961–6
- Silverman EK, Pierce JA, Province MA, et al. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Ann Intern Med 1989; 111(12):982–91
- Laurell CB, Eriksson S. The electro-phoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132–40
- Evans MD, Pryor WA. Cigarette smoking, emphysema, and damage to alpha1-proteinase inhibitor. Am J Physiol 1994; 266(1 Pt 1):L593–611 [Erratum, Am J Physiol 1995;268(1 Pt 1):section L following table of contents and 1995;268(6 Pt 3): section L following table of contents]
- Townley RG, Southard JG, Radford P, et al. Association of MS Pi phenotype with airway hyperresponsiveness. Chest 1990; 98(3):594–9
- Gaillard MC, Kilroe-Smith TA, Nogueira C, et al. Alpha-1-protease inhibitor in bronchial asthma: phenotypes and biochemical characteristics. Am Rev Respir Dis 1992;145(6):1311–5
- Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978;204(5): 345–51
- Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1985; 1(8421):152–4
- Hyde JS, Werner P, Kumar CM, et al. Protease inhibitor variants in children and young adults with chronic asthma. Ann Allergy 1979;43 (1):8–13
- Holden DA, Pàgliaccio L, Goormastic M, et al. Asthmatic presentation of alpha 1- antitrypsin (A1AT) deficiency: a clinical profile. (Abstr) Chest 1991;100(2):43S
- American Thoracic Society. Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. Am Rev Respir Dis 1989;140(5): 1494–7
- Brantly ML, Paul LD, Miller BH, et al. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988;138(2):327–36
- Cherniack NS. Chronic obstructive pulmonary disease. Philadelphia: Saunders, 1991
- Stoller JK, Smith P, Yang P, et al. Physical and social impact of alphar1 antitrypsin deficiency: results of a survey. Cleve Clin J Med 1994;61(6):461–7
- Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316(17): 1055–62